A multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparation.
about
Does intravenous immunoglobulin therapy prolong immunodeficiency in transient hypogammaglobulinemia of infancy?Considerations for dosing immunoglobulin in obese patients.A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency.Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.An open, prospective trial investigating the pharmacokinetics and safety, and the tolerability of escalating infusion rates of a 10% human normal immunoglobulin for intravenous infusion (IVIg), BT090, in patients with primary immunodeficiency diseasBroadening the translational immunology landscape.
P2860
A multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A multi-centre study of effica ...... us immunoglobulin preparation.
@en
type
label
A multi-centre study of effica ...... us immunoglobulin preparation.
@en
prefLabel
A multi-centre study of effica ...... us immunoglobulin preparation.
@en
P2093
P2860
P1476
A multi-centre study of effica ...... us immunoglobulin preparation.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2249.2010.04187.X
P577
2010-09-01T00:00:00Z